转自：证券时报 在A股市场持续走强并刷新10年新高的同时，中证转债指数1月6日也攀升走高，创下自2015年6月以来 的逾10年高点。 中证转债指数近期表现不仅延续了自2025年以来的强势格局，更凸显其在权益市场波动中"进可攻、退 可守"的独特价值。 中证转债指数刷新逾10年高点 1月6日，在权益市场强势走高，并刷新10年新高的背景下，中证转债指数也大涨1.35%，报505.77点， 创2015年6月以来高点。 此次行情的核心催化剂是脑机接口行业的商业化突破。特斯拉CEO埃隆·马斯克于2025年12月31日宣 布，旗下脑机接口公司Neuralink将于2026年启动设备大规模生产，并推进几乎完全自动化的手术方案。 这一表态被市场视为脑机接口从实验室走向大众消费的关键转折点。与此同时，国内政策支持力度持续 加码：国家药监局近期召开脑机接口医疗器械工作推进会，明确将加快相关产品审评审批流程；上海等 地出台专项行动方案，提出到2027年推动5款以上侵入式、半侵入式产品完成临床试验。 除塞力转债外，嘉美转债、联创转债等亦表现亮眼。嘉美包装股价大涨带动嘉美转债在1月5日涨 10.94%后，1月6日再度上涨14.95%，2 ...

Group 1 - The central bank will continue to implement a moderately loose monetary policy and increase counter-cyclical and cross-cyclical adjustment efforts [1] - Strong Brain Technology, a "unicorn" in brain-computer interface, has completed financing of approximately 2 billion yuan [1] - The Ministry of Commerce will strengthen export controls on dual-use items to Japan [1] Group 2 - The State Administration of Foreign Exchange is advancing the revision of the Foreign Exchange Management Regulations to build a higher standard international balance of payments statistical system [1] - In 2026, China will launch over 30 national standards in the data field [1] - Investment in water conservancy construction in China has exceeded 1 trillion yuan for four consecutive years [1] Group 3 - The China Automobile Dealers Association expects the automotive market to show a "good start" in January [1] - The State Administration of Foreign Exchange will orderly expand high-level opening pilot projects for cross-border trade and increase support for new trade formats such as cross-border e-commerce [1]

Group 1 - The core viewpoint of the news is that the brain-computer interface (BCI) sector is experiencing significant growth, highlighted by the recent 2 billion yuan financing of Qiangnao Technology, marking it as the second-largest financing in the field after Neuralink [2][3] - The BCI sector has become the hottest investment track in the A-share market since the beginning of 2026, with multiple stocks like Innovation Medical, Aipeng Medical, and Xiangyu Medical achieving consecutive trading limits [2] - Qiangnao Technology is recognized as one of the "Hangzhou Six Little Dragons," focusing on the research and development of BCI products, and has received FDA and CE certifications, making it one of the largest investors in BCI R&D globally [3][4] Group 2 - Qiangnao Technology was founded in February 2015 and has launched several products, including smart bionic limbs and brain-machine intelligent sleep devices [3] - The company has a strong investor lineup, including IDG, Huaden International, and several strategic investors, indicating robust market confidence [3] - The BCI industry is currently in a high-growth phase driven by policy support and technological breakthroughs, with expectations for Neuralink to begin large-scale production in 2026 [4] Group 3 - Several BCI stocks, including Sanbo Brain Science, Maillande, and Xiangyu Medical, have issued announcements regarding abnormal stock trading fluctuations, warning investors of potential risks [5] - Sanbo Brain Science reported a significant stock price increase but clarified that it does not engage in BCI product development, indicating minimal impact on its financial performance [7] - Xiangyu Medical highlighted its focus on non-invasive BCI technology and aims to commercialize its products in over a thousand top-tier hospitals by 2026 [11]

Group 1 - The Ministry of Commerce of China has decided to strengthen export controls on dual-use items to Japan, prohibiting all dual-use items from being exported to military users and any end-users that could enhance Japan's military capabilities [2][45][46] - China is considering tightening the export license review for medium and heavy rare earth items to Japan, which will be implemented starting April 4, 2025, under the Export Control Law [3][47] - China's Foreign Ministry has warned that Japan's recent moves towards militarization, including revising security documents to increase defense spending and develop offensive military capabilities, pose a danger to regional peace [4][48] Group 2 - The People's Bank of China has outlined seven key priorities for 2026, emphasizing the importance of monetary policy in promoting high-quality economic development and price stability, with a flexible approach to using tools like interest rate cuts [8][51] - A significant increase in new A-share accounts was reported, with 2.74369 million new accounts opened in 2025, marking a 9.75% year-on-year growth and the highest annual figure since 2022 [9][52][53] - The Shanghai Composite Index achieved a record 13 consecutive positive trading days, marking the longest streak in its history, with a 1.5% increase on January 6 [9][53] Group 3 - Financial regulators are conducting research to address barriers to long-term capital entering the market, focusing on enhancing the investment scale and proportion of bank wealth management products in A-shares [10][54] - The commercial aerospace sector continues to show strong growth potential, with expectations of a turning point in the industry [16][60] - The lithium carbonate market is experiencing a significant price increase at the start of the year due to tight supply and demand conditions [16][60]

Core Viewpoint - BrainCo, a prominent brain-computer interface (BCI) company in Hangzhou, has gained global attention due to its non-invasive technology and mass production capabilities, positioning itself as a competitor to Neuralink [1][2]. Group 1: Company Overview - Founded in 2015 by Harvard alumnus Han Bicheng, BrainCo is recognized as China's first BCI unicorn and has made significant advancements in non-invasive technology [1][2]. - The company has received major international certifications, including FDA and CE, and ranks among the top in global BCI research and development investments [2]. - BrainCo's flagship product, the BrainRobotics smart bionic hand, has been featured on the cover of TIME magazine's Best Inventions of the Year [2]. Group 2: Technological Innovations - BrainCo's core technology, the super sensor, captures weak brain signals without invasive procedures, enabling applications in rehabilitation for disabled individuals and treatment for conditions like autism and Alzheimer's [4]. - The company has successfully launched products such as the smart bionic hand and bionic leg, which allow users to perform complex movements, showcasing the practical impact of BCI technology [4]. Group 3: Market Position and Financing - BrainCo recently completed a financing round of approximately 2 billion RMB, making it the second-largest financing in the global BCI sector after Neuralink [5]. - The investment consortium includes renowned firms like IDG and strategic partners such as Lens Technology, indicating strong market confidence in BrainCo's potential [5]. - The company is preparing for an IPO, with plans to list in Hong Kong or on the STAR Market, reflecting its growth trajectory and market ambitions [5]. Group 4: Future Prospects - Han Bicheng envisions BCI technology transforming everyday life, with plans to assist 1 million disabled individuals and 10 million patients with brain-related conditions over the next 5 to 10 years [7]. - The demand for BCI solutions is significant, given that over 24 million people in China live with physical disabilities, alongside rising cases of brain diseases [7]. - BrainCo's growth is supported by Hangzhou's favorable innovation environment and government funding, which has been crucial for its development [8].

Core Viewpoint - The article highlights the rapid growth and investment activity in the brain-computer interface (BCI) sector, particularly focusing on the recent significant financing of Qiangnao Technology, which has raised approximately 2 billion yuan, marking it as the second-largest financing in the BCI field globally after Neuralink [2][3]. Investment Landscape - The BCI sector has emerged as a hot investment area in the A-share market since the beginning of 2026, with multiple stocks such as Innovation Medical, Aipeng Medical, and Xiangyu Medical experiencing consecutive trading gains [2]. - Qiangnao Technology, part of the "Hangzhou Six Little Dragons," has attracted a strong lineup of investors, including IDG and major tech firms, and has received FDA and CE certifications for its products [3][4]. Company Developments - Qiangnao Technology, founded in 2015, focuses on non-invasive BCI technology and has launched several products, including smart bionic limbs and brain-machine sleep aids [3]. - The company has a history of significant funding rounds, including a $400 million Series A round in 2019 and subsequent rounds totaling $30 million and $20 million in 2025 [4]. Market Dynamics - The BCI industry is currently experiencing a dual boost from policy support and technological breakthroughs, with expectations for Neuralink to begin large-scale production of BCI devices in 2026 [4]. - Companies like Sanbo Brain Science, Meilan De, and Xiangyu Medical have issued announcements regarding stock trading volatility, indicating the heightened interest and speculative nature of the market [5][6]. Product and Technology Focus - Xiangyu Medical is concentrating on non-invasive BCI technology and has made significant investments in R&D, with over 60% of its R&D budget directed towards BCI-related projects [7]. - The company aims to integrate BCI technology with its rehabilitation equipment, targeting to cover over 1,000 top-tier hospitals by 2026 [7].

Group 1: Market Performance - The A-share brain-computer interface (BCI) concept stocks surged recently, with the BCI index rising over 4% on January 6, reaching a historical high, and multiple BCI concept stocks achieving "two consecutive boards" [1] - Several listed companies issued announcements regarding stock trading anomalies, clarifying their involvement in BCI-related products and businesses [1] Group 2: Company Announcements - Sanbo Neuroscience (301293) stated that it specializes in high-end neurosurgery services and does not engage in BCI product development, with minimal impact on its revenue from neuro-regulation technology [2] - Aerospace Changfeng (600855) confirmed that it is not involved in BCI or commercial aerospace businesses, despite being categorized as a BCI concept stock [2] - Mylande announced that its BCI products are still in the research and market cultivation phase, with no significant impact on its performance [3] - Weisi Medical indicated that its BCI products are also in the early stages of market cultivation, focusing on non-invasive technology, with limited revenue contribution [3] - Xiangyu Medical highlighted its focus on non-invasive BCI technology and plans to cover over 1,000 top-tier hospitals by 2026, although its products have not yet achieved large-scale sales [4] Group 3: Industry Developments - Elon Musk announced that Neuralink will begin large-scale production of BCI devices in 2026, with a significant technological breakthrough that reduces surgical risks [5] - Several companies, including Yahui Long, signed strategic cooperation agreements to enhance market expansion for BCI products, although many products are still in early development stages [6][7] - Strong Brain Technology recently completed approximately 2 billion yuan in financing, becoming the second-largest financing in the BCI field after Neuralink [7][8] Group 4: Investment Insights - Open Source Securities suggested that the BCI market is in its commercialization early stage, recommending attention to both invasive and non-invasive clinical trial progress [8] - The report emphasized the scarcity of BCI-related targets in software, hardware, and experimental materials, indicating potential for significant revenue growth in the future [8]

Core Insights - The "15th Five-Year Plan" emphasizes the cultivation and expansion of emerging and future industries, aiming to create new pillar industries and strategically position future industries for growth [1] Group 1: Emerging Industries - During the "14th Five-Year Plan," China's emerging industries accelerated development, forming significant scale effects with several trillion-yuan market opportunities emerging by 2025 [2] - The commercial aerospace industry is on the verge of explosion, with advancements such as the successful launch of the Zhuque-3 rocket and accelerated deployment of satellite internet constellations [2] - The low-altitude economy is entering a commercial phase, marked by the issuance of operational certificates for manned civil unmanned aerial vehicles and the promotion of typical application scenarios by the Ministry of Transport [2] - New materials are crucial for breakthroughs in aerospace performance, with innovations in high-strength stainless steel and carbon fiber composites being utilized in key projects [2] Group 2: Energy Transition - China's energy transition has accelerated, establishing the world's largest power infrastructure and renewable energy systems, with plans to increase the share of renewable energy significantly by 2026 [3] - The "15th Five-Year Plan" aims to enhance emerging pillar industries, focusing on innovation in sectors like renewable energy, new materials, aerospace, and low-altitude economy [3] Group 3: Future Industries - Rapid advancements in future industries such as artificial intelligence, quantum information, and biomanufacturing have been noted, with significant breakthroughs achieved during the "14th Five-Year Plan" [4] - The development of 6G technology is prioritized, with expectations for commercial applications to begin around 2030, indicating a deep integration with AI [4][5] - Future industries are characterized by their potential to create new demands and economic forms, with quantum technology and nuclear fusion energy expected to play pivotal roles [6] Group 4: Market Opportunities and Challenges - Emerging industries are entering a rapid growth phase, with key scenarios being validated and replicable business models established, while future industries are still in the exploratory phase [7] - The uncertainty in future industries stems from both technological and commercial aspects, requiring significant R&D investment and policy support [8] - The collaboration between emerging and future industries is essential for driving new economic engines, with a focus on innovation and long-term value creation [9]

Market Overview - On January 6, the three major indices collectively rose, with the Shanghai Composite Index reaching a ten-year high. The total trading volume in A-shares was 2.83 trillion yuan, an increase of 265 billion yuan compared to the previous trading day. Over 4,100 stocks rose, with 143 stocks hitting the daily limit, marking two consecutive days of over a hundred stocks reaching the limit. The Shanghai Composite Index rose by 1.5%, the Shenzhen Component Index by 1.4%, and the ChiNext Index by 0.75% [1]. Commercial Aerospace and Brain-Computer Interface Concepts - The commercial aerospace concept continues to explode, while the brain-computer interface concept remains strong [1]. - Multiple stocks in the commercial aerospace and brain-computer interface sectors issued risk warnings after significant price increases [3]. Company-Specific Announcements - China Satellite announced that its stock price has increased by 156.07% since December 3, 2025, significantly outpacing the 23.92% increase in the military industry and the 5.31% increase in the Shanghai Composite Index. The company cautioned that its stock price is detached from its fundamentals, indicating a risk of a rapid price decline [4][5]. - China Satcom issued a warning about its stock price being severely detached from its fundamentals, highlighting a "hot potato" effect and significant trading risks [6]. - Beidou Star Communication noted that its stock price has deviated significantly from its fundamentals, with a cumulative increase of over 20% in three consecutive trading days, urging investors to be cautious [7]. - Aerospace Electronic reported a cumulative stock price increase of 123.23% since November 27, 2025, which is significantly higher than the industry and index increases, indicating potential market overheating and irrational speculation [9]. - Aerospace Universe stated that its stock price is at a historical high, with a projected revenue from commercial aerospace-related activities expected to be less than 15% of total revenue [11]. - Aerospace Changfeng clarified that it does not engage in brain-computer interface or commercial aerospace businesses, despite being categorized as such by the market [12]. - Sanbo Neuroscience announced that it does not involve itself in the research, production, or sales of brain-computer interface products, emphasizing minimal impact on its overall performance [13]. - Xiangyu Medical is focusing on non-invasive brain-computer interface technology but has not achieved large-scale sales as of the end of 2025 [14]. - Mylande stated that its products in the brain-computer interface field are still in the research and market cultivation phase, with no significant impact on its performance [15]. - The Shanghai Stock Exchange issued an inquiry to Yahui Long regarding its strategic cooperation with Brain Machine Star Chain Technology, requesting detailed disclosures about the partnership [16]. - Fenglong Co. announced that if its stock price continues to rise abnormally, it may apply for a trading suspension for verification, highlighting the high speculative risk [17].

Market Overview - US stock markets saw collective gains, with the Dow Jones up 0.99%, Nasdaq up 0.65%, and S&P 500 up 0.62%, both the Dow and S&P 500 reached historical closing highs [4] - The Philadelphia Semiconductor Index rose 2.75%, also hitting a historical high [4] - International oil prices dropped significantly, with WTI crude oil down 2.38% at $56.93 per barrel and Brent crude down 2.06% at $60.49 per barrel [5] - Gold prices increased, with spot gold up 0.97% at $4492.07 per ounce [5] - European stock indices closed higher, with Germany's DAX up 0.27%, France's CAC40 up 0.32%, and the UK's FTSE 100 up 1.18% [6] Government Policies - The Ministry of Commerce announced plans to enhance government guidance and increase support for green consumption policies, including subsidies for energy-efficient appliances and vehicles [7] - The Ministry of Commerce also issued a ban on the export of dual-use items to Japanese military users, effective immediately [8] - The People's Bank of China emphasized the continuation of a moderately loose monetary policy to support economic stability and high-quality development [9] Corporate Developments - Great Wall Motors has officially implemented a full weekend off policy for all employees, marking a significant shift in employee welfare practices [16] - GAC Honda announced a two-week production halt due to semiconductor supply issues and production line upgrades, indicating potential supply chain vulnerabilities [18] - The skincare brand Filorga announced the closure of its Tmall flagship store, citing a strategic business adjustment [20] - Bawang Tea reported on a food safety incident, confirming that the involved material was disposed of and the store is undergoing indefinite closure for rectification [23] - Strong Brain Technology, a brain-computer interface company, completed a significant financing round of approximately 2 billion yuan, highlighting the growing interest in the sector [25] - Tesla China introduced a five-year interest-free loan option for its Model 3 and Model Y vehicles, aiming to boost sales [26] Market Reactions - The Shanghai Composite Index achieved a record 13 consecutive days of gains, marking the longest winning streak in its history [11] - MiniMax's IPO saw an oversubscription of 1209 times, indicating strong market enthusiasm for innovative companies [31]